» Articles » PMID: 7852415

A 60-kDa Prion Protein (PrP) with Properties of Both the Normal and Scrapie-associated Forms of PrP

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1995 Feb 17
PMID 7852415
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Scrapie is a transmissible spongiform encephalopathy of sheep and other mammals in which disease appears to be caused by the accumulation of an abnormal form of a host protein, prion protein (PrP), in the brain and other tissues. The process by which the normal protease-sensitive form of PrP is converted into the abnormal protease-resistant form is unknown. Several hypotheses predict that oligomeric forms of either the normal or abnormal PrP may act as intermediates in the conversion process. We have now identified a 60-kDa PrP derived from hamster PrP expressed in murine neuroblastoma cells. Peptide mapping studies provided evidence that the 60-kDa PrP was composed solely of PrP and, based on its molecular mass, appeared to be a PrP dimer. The 60-kDa PrP was not dissociated under several harsh denaturing conditions, which indicated that it was covalently linked. It was similar to the disease-associated form of PrP in that it formed large aggregates. However, it resembled the normal form of PrP in that it was sensitive to proteinase K and had a short metabolic half-life. The 60-kDa PrP, therefore, had characteristics of both the normal and disease-associated forms of PrP. Formation and aggregation of the 60-kDa hamster PrP occurs in uninfected mouse neuroblastoma cells, which suggests that hamster PrP has a predisposition to aggregate even in the absence of scrapie infectivity. Similar 60-kDa PrP bands were identified in scrapie-infected hamster brain but not in uninfected brain. Therefore, a 60-kDa molecule might participate in the scrapie-associated conversion of protease-sensitive PrP to protease-resistant PrP.

Citing Articles

Evidence of Orientation-Dependent Early States of Prion Protein Misfolded Structures from Single Molecule Force Spectroscopy.

Raspadori A, Vignali V, Murello A, Giachin G, Samori B, Tanaka M Biology (Basel). 2022; 11(9).

PMID: 36138837 PMC: 9495685. DOI: 10.3390/biology11091358.


Novel quaternary structures of the human prion protein globular domain.

Bortot L, Rangel V, Pavlovici F, El Omari K, Wagner A, Brandao-Neto J Biochimie. 2021; 191:118-125.

PMID: 34517052 PMC: 8627497. DOI: 10.1016/j.biochi.2021.09.005.


Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review.

Dexter E, Kong Q Expert Rev Neurother. 2021; 21(9):969-982.

PMID: 34470561 PMC: 8453080. DOI: 10.1080/14737175.2021.1965881.


The G127V variant of the prion protein interferes with dimer formation in vitro but not in cellulo.

Sangeetham S, Engelke A, Fodor E, Krausz S, Tatzelt J, Welker E Sci Rep. 2021; 11(1):3116.

PMID: 33542378 PMC: 7862613. DOI: 10.1038/s41598-021-82647-w.


Structural effects of the highly protective V127 polymorphism on human prion protein.

Hosszu L, Conners R, Sangar D, Batchelor M, Sawyer E, Fisher S Commun Biol. 2020; 3(1):402.

PMID: 32728168 PMC: 7391680. DOI: 10.1038/s42003-020-01126-6.